Research ArticleCancer

Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma

See allHide authors and affiliations

Science Translational Medicine  23 Sep 2020:
Vol. 12, Issue 562, eaba4434
DOI: 10.1126/scitranslmed.aba4434

Article Information

vol. 12 no. 562

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication December 4, 2019
  • Resubmitted May 11, 2020
  • Accepted for publication July 30, 2020
  • .

Author Information

  1. Karin Hansson1,
  2. Katarzyna Radke1,
  3. Kristina Aaltonen1,
  4. Jani Saarela2,
  5. Adriana Mañas1,
  6. Jonas Sjölund1,
  7. Emma M. Smith3,
  8. Kristian Pietras1,
  9. Sven Påhlman1,
  10. Krister Wennerberg2,4,
  11. David Gisselsson5,6 and
  12. Daniel Bexell1,*
  1. 1Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, 223 81 Lund, Sweden.
  2. 2Institute for Molecular Medicine Finland, University of Helsinki, 00290 Helsinki, Finland.
  3. 3Division of Molecular Medicine and Gene Therapy, Lund Strategic Center for Stem Cell Biology, Lund University, 221 84 Lund, Sweden.
  4. 4BRIC - Biotech Research and Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark.
  5. 5Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, 221 85 Lund, Sweden.
  6. 6Department of Pathology, Laboratory Medicine, Medical Services, University Hospital, 221 84 Lund, Sweden.
  1. *Corresponding author. Email: daniel.bexell{at}med.lu.se

Altmetric

Article usage

Article usage: September 2020 to November 2020

AbstractFullPdf
Sep 20202900662219
Oct 2020970151109
Nov 20201874332

Stay Connected to Science Translational Medicine